相似文献
1
Perspectives on NMR in drug discovery: a technique comes of age.
Nat Rev Drug Discov. 2008 Sep;7(9):738-45. doi: 10.1038/nrd2606.
2
Perspectives of biomolecular NMR in drug discovery: the blessing and curse of versatility.
J Biomol NMR. 2007 Oct;39(2):87-90. doi: 10.1007/s10858-007-9183-5. Epub 2007 Aug 15.
3
NMR spectroscopy: the swiss army knife of drug discovery.
J Biomol NMR. 2020 Nov;74(10-11):509-519. doi: 10.1007/s10858-020-00330-0. Epub 2020 Jul 2.
4
Perspectives on Nuclear Magnetic Resonance Spectroscopy in Drug Discovery Research.
J Med Chem. 2024 Feb 8;67(3):1701-1733. doi: 10.1021/acs.jmedchem.3c02389. Epub 2024 Jan 30.
5
Applications of Solution NMR in Drug Discovery.
Molecules. 2021 Jan 22;26(3):576. doi: 10.3390/molecules26030576.
6
Polarization Transfer from Ligands Hyperpolarized by Dissolution Dynamic Nuclear Polarization for Screening in Drug Discovery.
ChemMedChem. 2015 Sep;10(9):1559-63. doi: 10.1002/cmdc.201500241. Epub 2015 Aug 4.
7
Reactions in NMR Tubes as Key Weapon in Rational Drug Design.
Methods Mol Biol. 2018;1824:417-430. doi: 10.1007/978-1-4939-8630-9_25.
8
Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
Methods Enzymol. 2011;493:469-85. doi: 10.1016/B978-0-12-381274-2.00018-2.
9
NMR in structure-based drug design.
Essays Biochem. 2017 Nov 8;61(5):485-493. doi: 10.1042/EBC20170037.
10
Revisiting biomolecular NMR spectroscopy for promoting small-molecule drug discovery.
J Biomol NMR. 2020 Nov;74(10-11):501-508. doi: 10.1007/s10858-020-00314-0. Epub 2020 Apr 18.
引用本文的文献
1
Targeting protein disorder: the next hurdle in drug discovery.
Nat Rev Drug Discov. 2025 Jun 9. doi: 10.1038/s41573-025-01220-6.
2
Fragment Screening Identifies Novel Allosteric Binders and Binding Sites in the VHR () Phosphatase.
ACS Omega. 2025 Jan 31;10(5):4912-4926. doi: 10.1021/acsomega.4c10321. eCollection 2025 Feb 11.
3
Exploring a Potential Optimization Route for Peptide Ligands of the Sam Domain from the Lipid Phosphatase Ship2.
Int J Mol Sci. 2024 Oct 2;25(19):10616. doi: 10.3390/ijms251910616.
4
COSMIC: Molecular Conformation Space Modeling in Internal Coordinates with an Adversarial Framework.
J Chem Inf Model. 2024 May 13;64(9):3610-3620. doi: 10.1021/acs.jcim.3c00989. Epub 2024 Apr 26.
5
Tools shaping drug discovery and development.
Biophys Rev (Melville). 2022 Jul 27;3(3):031301. doi: 10.1063/5.0087583. eCollection 2022 Sep.
6
Virtual Screening of Peptide Libraries: The Search for Peptide-Based Therapeutics Using Computational Tools.
Int J Mol Sci. 2024 Feb 1;25(3):1798. doi: 10.3390/ijms25031798.
7
NMR H,F-based screening of the four stem-looped structure 5_SL1-SL4 located in the 5'-untranslated region of SARS-CoV 2 RNA.
RSC Med Chem. 2023 Nov 28;15(1):165-177. doi: 10.1039/d3md00322a. eCollection 2024 Jan 25.
8
CarsiDock: a deep learning paradigm for accurate protein-ligand docking and screening based on large-scale pre-training.
Chem Sci. 2023 Dec 19;15(4):1449-1471. doi: 10.1039/d3sc05552c. eCollection 2024 Jan 24.
9
Optically Enhanced Solid-State H NMR Spectroscopy.
J Am Chem Soc. 2023 Jul 12;145(27):14874-14883. doi: 10.1021/jacs.3c03937. Epub 2023 Jun 27.
10
Degradants of Tenofovir Disoproxil Fumarate Under Forced Yet Mild Thermal Stress: Isolation, Comprehensive Structural Elucidation, and Mechanism.
AAPS PharmSciTech. 2023 Jun 22;24(6):139. doi: 10.1208/s12249-023-02598-5.
本文引用的文献
1
Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy.
Angew Chem Int Ed Engl. 1999 Jun 14;38(12):1784-1788. doi: 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q.
2
Phosphorus NMR spectroscopy as a versatile tool for compound library screening.
Angew Chem Int Ed Engl. 2008;47(14):2608-11. doi: 10.1002/anie.200705256.
3
A critical assessment of the performance of protein-ligand scoring functions based on NMR chemical shift perturbations.
J Med Chem. 2007 Oct 18;50(21):5128-34. doi: 10.1021/jm070484a. Epub 2007 Sep 15.
4
Perspectives of biomolecular NMR in drug discovery: the blessing and curse of versatility.
J Biomol NMR. 2007 Oct;39(2):87-90. doi: 10.1007/s10858-007-9183-5. Epub 2007 Aug 15.
5
NMR-based screening: a powerful tool in fragment-based drug discovery.
Analyst. 2007 Jul;132(7):693-705. doi: 10.1039/b709658p.
6
Water, water everywhere--except where it matters?
Drug Discov Today. 2007 Jul;12(13-14):534-9. doi: 10.1016/j.drudis.2007.05.004. Epub 2007 Jun 26.
7
A fragment-based approach for the discovery of isoform-specific p38alpha inhibitors.
ACS Chem Biol. 2007 May 22;2(5):329-36. doi: 10.1021/cb700025j. Epub 2007 Apr 27.
8
Development of molecular probes for second-site screening and design of protein tyrosine phosphatase inhibitors.
J Med Chem. 2007 May 3;50(9):2137-43. doi: 10.1021/jm061481l. Epub 2007 Mar 30.
9
Identification of novel fragment compounds targeted against the pY pocket of v-Src SH2 by computational and NMR screening and thermodynamic evaluation.
Proteins. 2007 Jun 1;67(4):981-90. doi: 10.1002/prot.21369.
10
Combined solid state and solution NMR studies of alpha,epsilon-15N labeled bovine rhodopsin.
J Biomol NMR. 2007 Apr;37(4):303-12. doi: 10.1007/s10858-007-9143-0. Epub 2007 Feb 23.
Zotero 插件